BACKGROUND: Even after years of stable response to therapy, patients with idiopathic pulmonary arterial hypertension (IPAH) may show an unexpected clinical deterioration due to progressive right ventricular (RV) failure. Therefore, the aim of this study was to assess in 5-year clinically stable patients with IPAH whether initial differences or subsequent changes in RV volumes precede late clinical progression. METHODS: Included were 22 clinically stable patients with IPAH as reflected by stable or improving New York Heart Association functional class II-III and exercise capacity during 5 years of follow-up. Twelve patients subsequently remained stable during a total follow-up of 10 years, whereas 10 other patients showed late progression le...
Background: In patients with idiopathic pulmonary hypertension (IPAH) progression of the disease and...
Abstract Right ventricular (RV) dilatation predicts clinical worsening in pulmonary arterial hyperte...
Pulmonary arterial hypertension (PAH) is a progressive, life-threatening, and incurable disease. Its...
BACKGROUND: Even after years of stable response to therapy, patients with idiopathic pulmonary arter...
ObjectivesThe purpose of this study was to examine the relationship between changes in pulmonary vas...
AIMS: This study investigated the relationship between right ventricular (RV) structure and function...
BACKGROUND: Right ventricular (RV) failure is a major determinant of symptoms and shortened survival...
Objectives: The purpose of this study was to examine the relationship between changes in pulmonary v...
BACKGROUND: Because the pathophysiology of idiopathic pulmonary arterial hypertension (IPAH) is an a...
Survival in patients with pulmonary arterial hypertension (PAH) is determined by right ventricular (...
Right ventricular (RV) failure is associated with poor outcomes in pulmonary hypertension (PH). We s...
Pulmonary arterial hypertension (PAH) is a right heart failure syndrome. The dominant symptom of PAH...
Right ventricular (RV) failure is associated with poor outcomes in pulmonary hypertension (PH). We s...
BACKGROUND: Although increased pulmonary pressure is caused by changes in the pulmonary vasculature,...
Objectives: To determine the prognostic value of patterns of right ventricular adaptation in patient...
Background: In patients with idiopathic pulmonary hypertension (IPAH) progression of the disease and...
Abstract Right ventricular (RV) dilatation predicts clinical worsening in pulmonary arterial hyperte...
Pulmonary arterial hypertension (PAH) is a progressive, life-threatening, and incurable disease. Its...
BACKGROUND: Even after years of stable response to therapy, patients with idiopathic pulmonary arter...
ObjectivesThe purpose of this study was to examine the relationship between changes in pulmonary vas...
AIMS: This study investigated the relationship between right ventricular (RV) structure and function...
BACKGROUND: Right ventricular (RV) failure is a major determinant of symptoms and shortened survival...
Objectives: The purpose of this study was to examine the relationship between changes in pulmonary v...
BACKGROUND: Because the pathophysiology of idiopathic pulmonary arterial hypertension (IPAH) is an a...
Survival in patients with pulmonary arterial hypertension (PAH) is determined by right ventricular (...
Right ventricular (RV) failure is associated with poor outcomes in pulmonary hypertension (PH). We s...
Pulmonary arterial hypertension (PAH) is a right heart failure syndrome. The dominant symptom of PAH...
Right ventricular (RV) failure is associated with poor outcomes in pulmonary hypertension (PH). We s...
BACKGROUND: Although increased pulmonary pressure is caused by changes in the pulmonary vasculature,...
Objectives: To determine the prognostic value of patterns of right ventricular adaptation in patient...
Background: In patients with idiopathic pulmonary hypertension (IPAH) progression of the disease and...
Abstract Right ventricular (RV) dilatation predicts clinical worsening in pulmonary arterial hyperte...
Pulmonary arterial hypertension (PAH) is a progressive, life-threatening, and incurable disease. Its...